What ? You must have been fired or did not get hired or the promotion you thought you deserved.
Don't be a hater. There are some folks that do very well in this division.
Sorry, it must suck to be you bitter person.
Dear Gattex leadership!
- Thread starter anonymous
- Start date
-
- Tags
- None
What ? You must have been fired or did not get hired or the promotion you thought you deserved.
Don't be a hater. There are some folks that do very well in this division.
Sorry, it must suck to be you bitter person.
With only about 700 patients on therapy how can anyone in sales be hitting goal? There has been 650-700 patients on therapy for the past 2 years. Price increases can only go so far to keep this boat afloat.
Fake volume - try and get a real vial by territory breakdown. Good luck. sb said just as they did with lialda- toss a number against a wall and go from there.
Hey if you're making money on volume then no complaints- once you stop making money on volume- major complainants and no real answers. A "real "rare Disease company will give you the "real" answer.
Current gi sales force will be competing with gi takeda sales force for a job to sell the ibs drug come 2019 if the deal goes through.
God, why did Shire get into rare diseases? Fucking idiots at this company
With the exception of Nathan this franchise is run by f’n idiots
700 patients on therapy nationwide... sounds like you are in the same boat we are in with Xiidra. With Jennifer Aniston doing commercials for us I thought we could at least get to 1000 scripts by now
700 patients currently on therapy is actually pretty good. Then problem is that Shire paid a bundle for this drug and expected the market to be significantly bigger. Not sure why. NPS said the market would peak about 4-5 years post launch and peak sales would never be over 400mm.
700 SBS patients are a lot of patients especially considering how many patients discontinue therapy.
This line of discussion is really dumb. Person that started it is bitter and low performer.
[QUOTE ]With the exception of Nathan this franchise is run by f’n idiots[/QUOTE]
Funny stuff
Funny stuff
The problem is Flemming has NO CLUE.
He OVERPAID for every company he acquired while at Shire. NPS, Baxalta, you name it.
When he wasn't busy overpaying he was spending $$$ like a drunken sailor with all his consolidating and ONE Shire BS.
HE's the REASON why Shire is in the mess it's in. He may save his ass in the end and get a big payday thanks to Takeda but his legacy with be that of a FAILED CEO at many companies NOT just Shire.
Flem made stockholders billions, while amassing tens of millions himself.
The gutter rats on here don't like success.
The gutter rats on here don't like success.
Never mind this jibber jabber. What's with all the vacancies across the country if there is so much business to be had ? One team has had almost compete turnover in 4 months including the manager and oas. Only ones still left there are - just grinning and waiting for the ibs drug.
I just spit out my rum and coke! Might want to add the big man to the idiot list. Great guy - but no clue and can't sell or lead his managers to lead their reps to sell this drug. Look at the turnover. Bring on IBS. He would rock that. Perfect big pharma role -reach, frequency, marketing messages, managed care, silly contests...homerun for everyone!!
Sounds like someone is sour grapes.
This must have been posted by one of his counterparts probably the dude running things into the ground out West from his spare bedroom turned office in the burbs of Chicago.